AbbVie SG&A Expenses 2010-2024 | ABBV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AbbVie annual sg&a expenses for 2024 were $14.752B, a 14.61% increase from 2023.
AbbVie annual sg&a expenses for 2023 were $12.872B, a 15.65% decline from 2022.
AbbVie annual sg&a expenses for 2022 were $15.26B, a 23.57% increase from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AbbVie annual sg&a expenses for 2024 were $14.752B, a 14.61% increase from 2023.
AbbVie annual sg&a expenses for 2023 were $12.872B, a 15.65% decline from 2022.
AbbVie annual sg&a expenses for 2022 were $15.26B, a 23.57% increase from 2021.